![c-MPL/TPOR (Mouse) ELISA, 27174 (RUO) | Mouse CMPL TPOR Enzyme-linked Immune-sorbent Assay Kit IBL-America c-MPL/TPOR (Mouse) ELISA, 27174 (RUO) | Mouse CMPL TPOR Enzyme-linked Immune-sorbent Assay Kit IBL-America](https://cdn11.bigcommerce.com/s-dpaty9ionu/images/stencil/1280x1280/products/6176/13019/apis7rtfv__49501.1578973877.jpg?c=2)
c-MPL/TPOR (Mouse) ELISA, 27174 (RUO) | Mouse CMPL TPOR Enzyme-linked Immune-sorbent Assay Kit IBL-America
![c‐MPL Is a Candidate Surface Marker and Confers Self‐Renewal, Quiescence, Chemotherapy Resistance, and Leukemia Initiation Potential in Leukemia Stem Cells - Li - 2018 - STEM CELLS - Wiley Online Library c‐MPL Is a Candidate Surface Marker and Confers Self‐Renewal, Quiescence, Chemotherapy Resistance, and Leukemia Initiation Potential in Leukemia Stem Cells - Li - 2018 - STEM CELLS - Wiley Online Library](https://stemcellsjournals.onlinelibrary.wiley.com/cms/asset/c9b59a40-f896-4b19-a299-dee659c543d1/stem2897-fig-0001-m.jpg)
c‐MPL Is a Candidate Surface Marker and Confers Self‐Renewal, Quiescence, Chemotherapy Resistance, and Leukemia Initiation Potential in Leukemia Stem Cells - Li - 2018 - STEM CELLS - Wiley Online Library
![Different mutations of the human c-mpl gene indicate distinct haematopoietic diseases | Journal of Hematology & Oncology | Full Text Different mutations of the human c-mpl gene indicate distinct haematopoietic diseases | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1756-8722-6-11/MediaObjects/13045_2012_Article_280_Fig1_HTML.jpg)
Different mutations of the human c-mpl gene indicate distinct haematopoietic diseases | Journal of Hematology & Oncology | Full Text
![c-Mpl-del, a c-Mpl alternative splicing isoform, promotes AMKL progression and chemoresistance | Cell Death & Disease c-Mpl-del, a c-Mpl alternative splicing isoform, promotes AMKL progression and chemoresistance | Cell Death & Disease](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41419-022-05315-5/MediaObjects/41419_2022_5315_Fig1_HTML.png)
c-Mpl-del, a c-Mpl alternative splicing isoform, promotes AMKL progression and chemoresistance | Cell Death & Disease
![Role of the Distal Half of the c-Mpl Intracellular Domain in Control of Platelet Production by Thrombopoietin In Vivo | Molecular and Cellular Biology Role of the Distal Half of the c-Mpl Intracellular Domain in Control of Platelet Production by Thrombopoietin In Vivo | Molecular and Cellular Biology](https://journals.asm.org/cms/10.1128/MCB.20.2.507-515.2000/asset/0c200406-1204-40ea-a5b1-5ef174276334/assets/graphic/mb0201369001.jpeg)
Role of the Distal Half of the c-Mpl Intracellular Domain in Control of Platelet Production by Thrombopoietin In Vivo | Molecular and Cellular Biology
![C‐Cbl regulates c‐MPL receptor trafficking and its internalization - Märklin - 2020 - Journal of Cellular and Molecular Medicine - Wiley Online Library C‐Cbl regulates c‐MPL receptor trafficking and its internalization - Märklin - 2020 - Journal of Cellular and Molecular Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/91e16e29-b147-4be2-a69e-d127ebd66ba7/jcmm15785-fig-0004-m.jpg)
C‐Cbl regulates c‐MPL receptor trafficking and its internalization - Märklin - 2020 - Journal of Cellular and Molecular Medicine - Wiley Online Library
![Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene c Mpl or CD110 or MPL) - Drugs in Development, 2021 Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene c Mpl or CD110 or MPL) - Drugs in Development, 2021](http://www.researchandmarkets.com/product_images/11364/11364845_500px_jpg/thrombopoietin_receptor_drugs_in_development_2021.jpg)
Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene c Mpl or CD110 or MPL) - Drugs in Development, 2021
The role of the thrombopoietin receptor MPL in myeloproliferative neoplasms: recent findings and potential therapeutic applicati
![Frontiers | The Thrombopoietin Receptor: Structural Basis of Traffic and Activation by Ligand, Mutations, Agonists, and Mutated Calreticulin Frontiers | The Thrombopoietin Receptor: Structural Basis of Traffic and Activation by Ligand, Mutations, Agonists, and Mutated Calreticulin](https://www.frontiersin.org/files/Articles/250740/fendo-08-00059-HTML/image_m/fendo-08-00059-g001.jpg)